Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| 1 |
Meta Platforms (Facebook)
META
|
+$499M |
| 2 |
AT&T
T
|
+$462M |
| 3 |
Amazon
AMZN
|
+$257M |
| 4 |
Procter & Gamble
PG
|
+$219M |
| 5 |
Verizon
VZ
|
+$185M |
Top Sells
| 1 |
TWX
Time Warner Inc
TWX
|
+$841M |
| 2 |
MON
Monsanto Co
MON
|
+$592M |
| 3 |
Apple
AAPL
|
+$140M |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$110M |
| 5 |
Royal Bank of Canada
RY
|
+$81M |
Sector Composition
| 1 | Technology | 18.01% |
| 2 | Financials | 15.74% |
| 3 | Healthcare | 13.25% |
| 4 | Consumer Discretionary | 10.32% |
| 5 | Industrials | 9.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CNSL
1976
DELISTED
Consolidated Communications Holdings, Inc.
CNSL
| $8.53M | ﹤0.01% |
689,829
+82,959
| +14% | +$1.03M |
|
|
CARO
1977
DELISTED
Carolina Financial Corp.
CARO
| $8.52M | ﹤0.01% |
198,615
+38,084
| +24% | +$1.63M |
|
1978
GSK
GSK
$82.2B
| $8.51M | ﹤0.01% |
168,942
+22,860
| +16% | +$1.15M |
|
|
FSCT
1979
DELISTED
ForeScout Technologies, Inc. Common Stock
FSCT
| $8.44M | ﹤0.01% |
246,445
+101,502
| +70% | +$3.48M |
|
|
DBD
1980
DELISTED
Diebold Nixdorf Incorporated
DBD
| $8.44M | ﹤0.01% |
706,356
+86,290
| +14% | +$1.03M |
|
1981
Dynavax Technologies
DVAX
$1.1B
| $8.43M | ﹤0.01% |
553,044
+56,752
| +11% | +$865K |
|
1982
Univest Financial
UVSP
$886M
| $8.43M | ﹤0.01% |
306,404
+31,815
| +12% | +$875K |
|
1983
Modine Manufacturing
MOD
$7.86B
| $8.42M | ﹤0.01% |
461,205
+44,808
| +11% | +$818K |
|
1984
Esperion Therapeutics
ESPR
$573M
| $8.41M | ﹤0.01% |
214,625
+35,882
| +20% | +$1.41M |
|
|
CARB
1985
DELISTED
Carbonite Inc
CARB
| $8.4M | ﹤0.01% |
240,663
+13,656
| +6% | +$477K |
|
1986
Artivion
AORT
$1.92B
| $8.4M | ﹤0.01% |
301,474
+26,271
| +10% | +$732K |
|
1987
Lattice Semiconductor
LSCC
$8.82B
| $8.38M | ﹤0.01% |
1,277,485
+67,649
| +6% | +$444K |
|
1988
Ovintiv
OVV
$10.8B
| $8.36M | ﹤0.01% |
129,343
+7,614
| +6% | +$492K |
|
1989
RE/MAX Holdings
RMAX
$195M
| $8.36M | ﹤0.01% |
159,411
+9,131
| +6% | +$479K |
|
|
RCM
1990
DELISTED
R1 RCM Inc. Common Stock
RCM
| $8.35M | ﹤0.01% |
962,033
+154,722
| +19% | +$1.34M |
|
|
RVNC
1991
DELISTED
Revance Therapeutics, Inc.
RVNC
| $8.35M | ﹤0.01% |
304,089
+41,697
| +16% | +$1.14M |
|
|
ECYT
1992
DELISTED
Endocyte, Inc. Common Stock
ECYT
| $8.35M | ﹤0.01% |
604,743
+219,961
| +57% | +$3.04M |
|
|
CAMP
1993
DELISTED
CalAmp Corp.
CAMP
| $8.34M | ﹤0.01% |
15,483
+1,787
| +13% | +$963K |
|
|
EIGI
1994
DELISTED
Endurance International Group Holdings, Inc.
EIGI
| $8.34M | ﹤0.01% |
838,308
+123,280
| +17% | +$1.23M |
|
1995
MasterCraft Boat Holdings
MCFT
$362M
| $8.34M | ﹤0.01% |
287,912
+25,104
| +10% | +$727K |
|
1996
Adeia
ADEA
$1.71B
| $8.33M | ﹤0.01% |
1,954,615
-36,458
| -2% | -$155K |
|
1997
Weis Markets
WMK
$1.75B
| $8.32M | ﹤0.01% |
155,950
+20,566
| +15% | +$1.1M |
|
1998
Simply Good Foods
SMPL
$2.73B
| $8.31M | ﹤0.01% |
575,511
+151,367
| +36% | +$2.19M |
|
1999
CytomX Therapeutics
CTMX
$330M
| $8.3M | ﹤0.01% |
363,128
+32,854
| +10% | +$751K |
|
2000
Omeros
OMER
$282M
| $8.3M | ﹤0.01% |
457,605
+58,000
| +15% | +$1.05M |
|